{{Rsnum
|rsid=3813627
|Gene=APOA2
|Chromosome=1
|position=161225358
|Orientation=plus
|GMAF=0.3375
|Gene_s=APOA2,TOMM40L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 42.5 | 49.6 | 8.0
| HCB | 27.7 | 49.6 | 22.6
| JPT | 16.8 | 52.2 | 31.0
| YRI | 89.8 | 10.2 | 0.0
| ASW | 71.9 | 26.3 | 1.8
| CHB | 27.7 | 49.6 | 22.6
| CHD | 28.4 | 43.1 | 28.4
| GIH | 41.6 | 47.5 | 10.9
| LWK | 81.8 | 18.2 | 0.0
| MEX | 29.3 | 50.0 | 20.7
| MKK | 79.5 | 18.6 | 1.9
| TSI | 32.4 | 52.9 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20855565
|Title=Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease
|OA=1
}}

{{PMID|19878569|OA=1
}} Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.

{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}